Musely Lands $360 Million From General Catalyst In Equity-Free Deal

Telehealth skin and hair care brand Musely has locked in $360 million in fresh capital from General Catalyst. The massive deal is notable for its structure: the funding is non-dilutive, meaning Musely retains full ownership and control without having to surrender equity. This move allows the company to fuel aggressive growth plans while keeping its cap table intact.

The direct-to-consumer brand, which specializes in prescription-grade treatments for skin conditions, hair loss, and menopause, plans to use the capital to supercharge its customer acquisition efforts. By leveraging General Catalyst’s "Customer Value Adjustment" model, Musely can treat marketing spend as an asset, bridging the gap between high-cost customer acquisition and long-term recurring revenue.

The deal highlights a growing trend among successful late-stage startups looking for creative ways to scale without traditional venture capital dilution. As the brand eyes a larger share of the wellness market, this influx of cash provides a significant war chest to outpace competitors in the crowded telehealth space. Observers will be watching to see how quickly Musely can convert this investment into a larger, loyal subscriber base.

This report is based on reporting from TechCrunch.